Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMAT - AN 20/04
DRKS00003518Phase 2Active, not recruiting
- Sponsor
- Universitätsmedizin Essen
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in clear cell renal cell carcinoma (ccRCC) and bronchial carcinoma comparing Adjuvant Sutent with Adjuvant placebo (2 arms). Started Jan 2012; status: active, not recruiting.
02
Drugs
sunitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)bronchial carcinoma
Beyond the preview
Go deeper on DRKS00003518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003518.